These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29213224)

  • 1. Pro-arrhythmogenic Effects of the V141M KCNQ1 Mutation in Short QT Syndrome and Its Potential Therapeutic Targets: Insights from Modeling.
    Lee HC; Rudy Y; Liang H; Chen CC; Luo CH; Sheu SH; Cui J
    J Med Biol Eng; 2017 Oct; 37(5):780-789. PubMed ID: 29213224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of KCNQ1 alternative splicing regulates cardiac IKs and action potential repolarization.
    Lee HC; Rudy Y; Po-Yuan P; Sheu SH; Chang JG; Cui J
    Heart Rhythm; 2013 Aug; 10(8):1220-8. PubMed ID: 23608591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillation.
    Campbell CM; Campbell JD; Thompson CH; Galimberti ES; Darbar D; Vanoye CG; George AL
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):960-6. PubMed ID: 24006450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero.
    Hong K; Piper DR; Diaz-Valdecantos A; Brugada J; Oliva A; Burashnikov E; Santos-de-Soto J; Grueso-Montero J; Diaz-Enfante E; Brugada P; Sachse F; Sanguinetti MC; Brugada R
    Cardiovasc Res; 2005 Dec; 68(3):433-40. PubMed ID: 16109388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Atrial Arrhythmogenesis and Sinus Bradycardia in
    Whittaker DG; Colman MA; Ni H; Hancox JC; Zhang H
    Front Physiol; 2018; 9():1402. PubMed ID: 30337886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
    Bodi I; Franke G; Pantulu ND; Wu K; Perez-Feliz S; Bode C; Zehender M; zur Hausen A; Brunner M; Odening KE
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1163-71. PubMed ID: 23718892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular mechanism for adrenergic-induced long QT syndrome.
    Wu J; Naiki N; Ding WG; Ohno S; Kato K; Zang WJ; Delisle BP; Matsuura H; Horie M
    J Am Coll Cardiol; 2014 Mar; 63(8):819-27. PubMed ID: 24184248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms by which atrial fibrillation-associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels.
    Restier L; Cheng L; Sanguinetti MC
    J Physiol; 2008 Sep; 586(17):4179-91. PubMed ID: 18599533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel KCNQ1 missense mutation identified in a patient with juvenile-onset atrial fibrillation causes constitutively open IKs channels.
    Hasegawa K; Ohno S; Ashihara T; Itoh H; Ding WG; Toyoda F; Makiyama T; Aoki H; Nakamura Y; Delisle BP; Matsuura H; Horie M
    Heart Rhythm; 2014 Jan; 11(1):67-75. PubMed ID: 24096004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico investigation of a KCNQ1 mutation associated with short QT syndrome.
    Adeniran I; Whittaker DG; El Harchi A; Hancox JC; Zhang H
    Sci Rep; 2017 Aug; 7(1):8469. PubMed ID: 28814790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological rescue of specific long QT variants of KCNQ1/KCNE1 channels.
    Zou X; Wu X; Sampson KJ; Colecraft HM; Larsson HP; Kass RS
    Front Physiol; 2022; 13():902224. PubMed ID: 36505078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-QT mutation p.K557E-Kv7.1: dominant-negative suppression of IKs, but preserved cAMP-dependent up-regulation.
    Spätjens RL; Bébarová M; Seyen SR; Lentink V; Jongbloed RJ; Arens YH; Heijman J; Volders PG
    Cardiovasc Res; 2014 Oct; 104(1):216-25. PubMed ID: 25139741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome.
    Moreno C; Oliveras A; de la Cruz A; Bartolucci C; Muñoz C; Salar E; Gimeno JR; Severi S; Comes N; Felipe A; González T; Lambiase P; Valenzuela C
    Cardiovasc Res; 2015 Sep; 107(4):613-23. PubMed ID: 26168993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gating mechanisms underlying deactivation slowing by two KCNQ1 atrial fibrillation mutations.
    Peng G; Barro-Soria R; Sampson KJ; Larsson HP; Kass RS
    Sci Rep; 2017 Apr; 7():45911. PubMed ID: 28383569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repolarisation and vulnerability to re-entry in the human heart with short QT syndrome arising from KCNQ1 mutation--a simulation study.
    Zhang H; Kharche S; Holden AV; Hancox JC
    Prog Biophys Mol Biol; 2008; 96(1-3):112-31. PubMed ID: 17905416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel
    Nakajima T; Tamura S; Kawabata-Iwakawa R; Itoh H; Hasegawa H; Kobari T; Harasawa S; Sekine A; Nishiyama M; Kurabayashi M; Imoto K; Kaneko Y; Nakatani Y; Horie M; Ishii H
    Front Physiol; 2024; 15():1401822. PubMed ID: 39100276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.
    Aromolaran AS; Subramanyam P; Chang DD; Kobertz WR; Colecraft HM
    Cardiovasc Res; 2014 Dec; 104(3):501-11. PubMed ID: 25344363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin acts as an atypical KCNQ1/KCNE1-current activator and reverses long QT in insulin-resistant aged rats by accelerating the ventricular action potential repolarization through affecting the β
    Olgar Y; Durak A; Bitirim CV; Tuncay E; Turan B
    J Cell Physiol; 2022 Feb; 237(2):1353-1371. PubMed ID: 34632595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
    El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
    J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.
    Luo C; Wang K; Zhang H
    Biomed Eng Online; 2017 Jun; 16(1):69. PubMed ID: 28592292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.